Reuters Health Report

Click to View in Browser 02/7/2014 Flavor-pairing may teach kids to like vegetables NEW YORK (Reuters Health) - Parents have long poured on cheese sauce, peanut butter and the like to coax kids to eat their vegetables, but a new study suggests those tricks might also get children to look more favorably at the vegetables themselves. Merck to pay $100 million in NuvaRing contraceptive settlement (Reuters) - Merck & Co said on Friday it will pay $100 million to resolve all U.S. product liability lawsuits alleging it downplayed serious health risks involving its NuvaRing intrauterine contraceptive device. Fortified foods make up for some missing nutrients: study NEW YORK (Reuters Health) - Fortification of foods with additional nutrients does have an impact on kids' intake of vitamins and minerals, but many children and teens are still not getting adequate nutrition, according to a new U.S. study. A low-sodium diet is still the best bet: study NEW YORK (Reuters Health) - Eating less than one teaspoon of salt per day remains the ideal goal for Americans, according to a new study. Tests to show water safety after coal ash spill in North Carolina WINSTON-SALEM, North Carolina (Reuters) - As many as 82,000 tons of ash have spilled into a river after a pipe break at a retired coal plant in North Carolina, and environmental officials said on Thursday that preliminary water quality tests showed no violations of state standards. Thirty Minnesota school children treated for carbon monoxide MINNEAPOLIS (Reuters) - A southern Minnesota school building was evacuated on Thursday and 30 elementary students were treated at a local hospital for possible carbon monoxide poisoning, officials said. Big Pharma pushes for U.S. action against India over patent worries MUMBAI/LONDON (Reuters) - Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said. Shire's ADHD drug Vyvanse fails in trial to treat depression (Reuters) - Shire Plc's Vyvanse, a top-selling medicine for hyperactivity, failed in two late-stage clinical trials to successfully treat adults with major depressive disorders, the pharmaceutical group said late on Thursday. U.S. group issues stroke prevention guidelines just for women CHICAGO (Reuters) - While stroke is common in both men and women, guidelines released on Thursday for the first time address factors such as pregnancy, birth control pills and menopause that put women at particular risk for the deadly condition. Does a nose job affect the voice? NEW YORK (Reuters Health) - People who went under the knife for nose jobs sounded a bit more nasal five months after the surgery, according to a new study from Iran. Related Video Entrepreneurs turn pollution into plastic Messy winter storm dumps snow, ice on Northeast The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend